ARCpoint Inc
ARC
Minas Metals Ltd
MINA
Quri-Mayu Developments Ltd
QURI
KGL Resources Ltd
KGL.H
Alerio Gold Corp
ALE
CA Stock MarketDetailed Quotes
TTI Thiogenesis Therapeutics Corp
- 0.610
- +0.020+3.39%
15min DelayMarket Closed Dec 13 16:00 ET
28.08MMarket Cap-6.78P/E (TTM)
0.610High0.580Low42.00KVolume0.580Open0.590Pre Close24.44KTurnover1.06052wk High0.12%Turnover Ratio46.03MShares0.52052wk Low-0.09EPS TTM21.56MFloat Cap1.060Historical HighLossP/E (Static)35.34MShs Float0.375Historical Low-0.13EPS LYR5.09%Amplitude--Dividend TTM6.78P/B1Lot Size--Div YieldTTM
Thiogenesis Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -38.12%677.78K | -16.67%731.71K | -22.91%853.32K | 163.62%5.21M | 291.84%2.13M | 55.16%1.1M | 76.63%878.08K | 382.79%1.11M | 54.40%1.97M | 43.08%542.49K |
| Selling and administrative expenses | 18.18%272.93K | 30.52%263.16K | 22.27%281.89K | 11.79%1.04M | -26.05%338.27K | 27.31%230.95K | -11.01%201.62K | 317.85%230.55K | 204.28%933.09K | 508.61%457.45K |
| -General and administrative expense | 18.18%272.93K | 30.52%263.16K | 22.27%281.89K | 11.79%1.04M | -26.05%338.27K | 27.31%230.95K | -11.01%201.62K | 317.85%230.55K | 204.28%933.09K | 508.61%457.45K |
| Research and development costs | -53.16%404.86K | -30.73%468.56K | -34.80%571.43K | 286.93%4.16M | 1,399.84%1.79M | 64.79%864.36K | 150.02%676.46K | 403.37%876.4K | -21.23%1.08M | -74.43%119.17K |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 91.32%-34.13K | ---- |
| Operating profit | 38.12%-677.78K | 16.67%-731.71K | 22.91%-853.32K | -163.62%-5.21M | -291.84%-2.13M | -55.16%-1.1M | -76.63%-878.08K | -382.79%-1.11M | -54.40%-1.97M | -43.08%-542.49K |
| Net non-operating interest income (expenses) | 8.24%48.62K | 14.90%57.68K | 48.13%59.64K | 8,217.06%171.17K | 565.63%35.78K | 28,879.35%44.92K | 50.2K | 1,259.56%40.26K | 168.53%2.06K | 9.14%5.38K |
| Non-operating interest income | 8.24%48.62K | 14.90%57.68K | 48.13%59.64K | 2,669.21%171.17K | 478.94%35.78K | 28,879.35%44.92K | --50.2K | --40.26K | --6.18K | --6.18K |
| Non-operating interest expense | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 37.30%4.12K | 120.84%805 |
| Other net income (expenses) | -566.13%-27.69K | 153.41%22.71K | 83.12K | 98.56%-28.16K | -79.82%18.52K | -4.16K | -42.52K | -3,158.38%-1.95M | 149.96%91.77K | |
| Gain on sale of security | -566.13%-27.69K | 153.41%22.71K | --83.12K | -145.81%-28.16K | -85.86%18.52K | ---4.16K | ---42.52K | ---- | -3.67%61.47K | 256.67%130.95K |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---5.27K | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5.27K | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2.01M | ---33.9K |
| Income before tax | 37.71%-656.86K | 25.17%-651.32K | 33.38%-710.57K | -29.02%-5.06M | -365.12%-2.07M | -49.42%-1.05M | -75.08%-870.39K | 53.13%-1.07M | -222.12%-3.92M | -31.95%-445.34K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 37.71%-656.86K | 25.17%-651.32K | 33.38%-710.57K | -29.02%-5.06M | -365.12%-2.07M | -49.42%-1.05M | -75.08%-870.39K | 53.13%-1.07M | -222.12%-3.92M | -31.95%-445.34K |
| Net income continuous operations | 37.71%-656.86K | 25.17%-651.32K | 33.38%-710.57K | -29.02%-5.06M | -365.12%-2.07M | -49.42%-1.05M | -75.08%-870.39K | 53.13%-1.07M | -222.12%-3.92M | -31.95%-445.34K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 37.71%-656.86K | 25.17%-651.32K | 33.38%-710.57K | -29.02%-5.06M | -365.12%-2.07M | -49.42%-1.05M | -75.08%-870.39K | 53.13%-1.07M | -222.12%-3.92M | -31.95%-445.34K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 37.71%-656.86K | 25.17%-651.32K | 33.38%-710.57K | -29.02%-5.06M | -365.12%-2.07M | -49.42%-1.05M | -75.08%-870.39K | 53.13%-1.07M | -222.12%-3.92M | -31.95%-445.34K |
| Diluted earnings per share | 66.67%-0.01 | 50.00%-0.01 | 33.33%-0.02 | 18.75%-0.13 | -400.00%-0.05 | -50.00%-0.03 | 89.47%-0.02 | 63.21%-0.03 | -266.56%-0.16 | 17.30%-0.01 |
| Basic earnings per share | 66.67%-0.01 | 50.00%-0.01 | 33.33%-0.02 | 18.75%-0.13 | -400.00%-0.05 | -50.00%-0.03 | 89.47%-0.02 | 63.21%-0.03 | -266.56%-0.16 | 17.30%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.